Skip to main content

stock

UTHR · UNITED THERAPEUTICS Corp

What UNITED THERAPEUTICS Corp reports to the SEC, read from its filings.

Open in the app

Price

The live UTHR price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on UTHR.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
42,890,692 as of 2026-07-29 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
86.1%
Operating
44.4%
Net
41.6%

Returns

ROE
20.5%
ROA
18.2%

Health

Current ratio
5.7x
Debt/equity
—

Deep value

NCAV
$2.66B
NCAV per share
$62.11
Price/NCAV
Locked
NNWC
$1.31B
NNWC per share
$30.61
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$783.30M$683.80M$330.80M$333.00M
10-Q filed 2026-08-05
2026-03-31$781.50M$648.10M$325.80M$274.90M
10-Q filed 2026-05-06
2025-12-31$790.20M$686.80M$356.70M$364.30M
DEF 14A filed 2026-04-29
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$799.50M$698.60M$388.50M$338.70M
10-Q filed 2025-10-29
2025-06-30$798.60M$711.00M$364.50M$309.50M
10-Q filed 2026-08-05
2025-03-31$794.40M$701.90M$382.80M$322.20M
10-Q filed 2026-05-06
2024-12-31$735.90M$660.00M$357.70M$301.30M
DEF 14A filed 2026-04-29
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$748.90M$665.80M$343.10M$309.10M
10-Q filed 2025-10-29
Assets
$7.22B
Equity
$6.40B

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$3.18B$1.49B$1.33B$1.04B
2024-12-31$2.88B$1.38B$1.20B$1.08B
2023-12-31$2.33B$1.18B$984.80M$747.60M
2022-12-31$1.94B$979.70M$727.30M$663.70M
2021-12-31$1.69B$555.90M$475.80M$477.40M
2020-12-31$1.48B$593.60M—$696.40M
2019-12-31$1.45B-$187.60M-$104.50M-$290.30M
2018-12-31$1.63B$805.40M$589.20M$594.00M
2017-12-31$1.73B$814.90M$417.90M$387.90M
2016-12-31$1.60B$1.06B$713.70M$605.60M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named UTHR, and the market events around them.

Sign in to see this

Board

The UTHR board could not be loaded.

Retry the UTHR board

nakagai

Signals on UTHR come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the UTHR board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

UNITED THERAPEUTICS Corp (UTHR): SEC filings, financials and insider trades · Nakagai